Looking for the Best Model to Predict Hepatocellular Carcinoma Recurrence After Liver Transplantation in Latin America
Federico Piñero, Aline Chagas, Ilka Boin – 9 September 2020
Con: Liver Biopsy Remains the Gold Standard to Evaluate Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Daniel Berger, Vishal Desai, Sujit Janardhan – 9 September 2020
Pro: Noninvasive Imaging Has Replaced Biopsy as the Gold Standard in the Evaluation of Nonalcoholic Fatty Liver Disease
Shaham Mumtaz, Nathan Schomaker, Natasha Von Roenn – 9 September 2020
Pro: Noninvasive Imaging Has Replaced Biopsy as the Gold Standard in the Evaluation of Nonalcoholic Fatty Liver Disease
Shaham Mumtaz, Nathan Schomaker, Natasha Von Roenn – 9 September 2020
Which Strategies Should Be Implemented in Latin America to Eradicate Hepatitis C Virus by 2030?
Ezequiel Ridruejo, Alejandro Soza – 9 September 2020
Con: Liver Biopsy Remains the Gold Standard to Evaluate Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Daniel Berger, Vishal Desai, Sujit Janardhan – 9 September 2020
Obesity and Liver Decompensation
Joseph C. Ahn, Vinay Sundaram – 9 September 2020
Letter to the Editor: Liver Biochemistries in Hospitalized Chinese Patients With Severe Coronavirus Disease 2019
Ya Gao, Ming Liu, Shuzhen Shi, Jinhui Tian – 8 September 2020
Graft Programmed Death Ligand 1 Expression as a Marker for Transplant Rejection Following Anti–Programmed Death 1 Immunotherapy for Recurrent Liver Tumors
Guo‐Ming Shi, Jiping Wang, Xiao‐Wu Huang, Xiao‐Yong Huang, Yi‐Feng He, Yuan Ji, Yi Chen, Dong Wu, Jia‐Cheng Lu, Qi‐Man Sun, Wei‐Ren Liu, Ting Wang, Liu‐Xiao Yang, Ying‐Yong Hou, Ying‐Hong Shi, Jian Sun, Yong‐Sheng Xiao, Zheng Wang, Jia Fan, Monica M. Bertagnolli, Jian Zhou – 8 September 2020